Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

BASF SE

Start price
Target price
Perf. (%)
€65.55
06.01.20
-
06.03.20
-20.35%
06.03.20

Increased challenges to pay loans and raise capital
Higher risks for its business
Low dividend yield expected
buy
BELLUS Health Inc.

Start price
Target price
Perf. (%)
€2.80
04.01.20
-
04.11.21
112.50%
05.11.21

Could be worthwhile Investment >10% per year
buy
Delivery Hero SE

Start price
Target price
Perf. (%)
€70.22
04.01.20
€150.00
04.11.21
87.27%
06.09.21

Could be worthwhile Investment >10% per year
buy
Nemetschek SE

Start price
Target price
Perf. (%)
€61.45
04.01.20
€61.00
04.11.21
77.87%
05.11.21

Could be worthwhile Investment >10% per year
buy
CA Immobilien Anlagen AG

Start price
Target price
Perf. (%)
€37.85
03.01.20
€45.00
04.11.21
-5.81%
28.05.21

Could be worthwhile Investment >10% per year
Small cyclical dependencies
Known brand
Microchip Tech.

Start price
Target price
Perf. (%)
€48.28
02.01.20
€29.00
04.11.21
13.41%
16.11.20

buy
Watsco Inc. A

Start price
Target price
Perf. (%)
€159.00
02.01.20
€200.00
27.07.20
22.64%
27.07.20

buy
Beyond Meat Inc

Start price
Target price
Perf. (%)
€67.31
31.12.19
€85.00
11.01.20
33.71%
11.01.20

Revenue growth >5% per year expected
buy
Alteryx Inc

Start price
Target price
Perf. (%)
€92.42
30.12.19
€75.00
04.11.21
-24.06%
05.11.21

Stable Large shareholder and/or long term investor
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Risky balance sheet
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€83.00
22.12.19
€79.00
04.11.21
-3.61%
05.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€18.00
21.12.19
€30.00
04.11.21
-36.06%
05.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
buy
OHB SE

Start price
Target price
Perf. (%)
€45.25
21.12.19
-
04.11.21
-13.70%
05.11.21

Top Rating
Good culture
Very differentiated customer and product portfolio
Small Risks for its business
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€59.38
20.12.19
€86.00
23.04.20
21.40%
23.04.20

buy
Fedex Corp.

Start price
Target price
Perf. (%)
€136.70
18.12.19
€150.00
18.12.19
-3.16%
18.12.19

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Boeing Co.

Start price
Target price
Perf. (%)
€293.45
17.12.19
€260.00
20.10.20
-51.60%
20.10.20

buy
Adamas Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€3.46
17.12.19
€6.00
04.11.21
103.76%
05.11.21

buy
Nokia Corp.

Start price
Target price
Perf. (%)
€3.24
16.12.19
€4.00
28.01.20
10.68%
28.01.20

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
High dividend yield expected
buy
Paypal Holdings Inc

Start price
Target price
Perf. (%)
€97.17
16.12.19
-
04.11.21
103.09%
05.11.21

Bitcoin

Start price
Target price
Perf. (%)
€6,538.1
13.12.19
-
04.11.21
712.06%
05.11.21

buy
EVN AG

Start price
Target price
Perf. (%)
€16.58
12.12.19
€20.00
12.03.20
-23.64%
12.03.20

Enochian Biosciences Inc

Start price
Target price
Perf. (%)
€5.65
11.12.19
€0.000
04.11.21
-2.65%
26.08.21

buy
TeamViewer AG

Start price
Target price
Perf. (%)
€28.94
11.12.19
€20.00
04.11.21
-56.03%
01.11.21

EBIT growth >5% per year expected
Normal challenges to pay loans and raise capital
ROE lower than 10% per year
Below average Management
buy
Inditex S.A.

Start price
Target price
Perf. (%)
€29.74
11.12.19
€35.00
31.01.20
1.48%
31.01.20

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Sustainability is important
buy
Delta Air Lines Inc.

Start price
Target price
Perf. (%)
€49.87
11.12.19
€80.00
27.02.20
-10.17%
27.02.20

buy
Larimar Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.94
10.12.19
€13.00
04.11.21
20.81%
05.11.21

Could be worthwhile Investment >10% per year